Drug Discovery

actavis-new-drug-application-nda-for-progestin-only-transdermal-contraceptive-patch-norethindrone-transdermal-delivery-system-gets-fda-nod

Actavis 'pregnancy preventer' gets FDA nod

  • US
  • |
  • News

Singapore: US FDA has accepted Actavis' New Drug Application (NDA) for a progestin-only transdermal contraceptive patch (Norethindrone Transdermal Delivery System) for use by women to prevent pregnancy. The acceptance of the NDA for... Read more

gilead-leukemia-study-gets-complete-repsonse

Gilead leukemia study gets complete response


  • Australia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Gilead Sciences' phase II study (Study 101-08) evaluating idelalisib (formerly GS-1101), an investigational, targeted,... Read more

bioduro-opens-discovery-lab-in-shanghai

BioDuro opens discovery lab in Shanghai


  • China
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: BioDuro, a PPD Company, has opened a new state-of-the-art laboratory in Shanghai, China, strengthening its ability... Read more

us-fda-approves-cervarix-for-use-in-females-aged-nine-to-25-years

Now 9-yr-old girls can use Cervarix for cancer

  • US
  • |
  • Regulatory
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Cervarix has now been approved for use in females aged nine-to-25 years to prevent persistent infection, premalignant cervical... Read more

regeneron-acquires-rights-to-sanofi-s-ophthalmology-antibodies-targeting-the-pdgf-platelet-derived-growth-factor-and-ang2-angiopoietin2

Regeneron acquires Sanofi eye care antibodies

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: US-based Regeneron Pharmaceuticals has acquired exclusive rights to two families of novel antibodies from Sanofi. Regeneron acquired... Read more

novartis-follows-time-warner-twitter-to-join-malaria-campaign

Novartis follows Time Warner, Twitter to join malaria campaign

Singapore: Novartis and Malaria No More, a leading global charity to end malaria deaths, are joining forces on the Power of One campaign... Read more

the-who-is-concerned-that-in-the-south-east-asia-region-the-malaria-parasite-is-becoming-resistant-to-some-of-the-drugs-that-have-helped-make-progress

WHO launches emergency response to drug resistance

  • Rest of Asia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: On World Malaria Day, April 25, the WHO recognized significant accomplishments made in preventing and controlling malaria in... Read more

good-news-for-ischemia-patients-phylogica-gets-european-patent-for-its-peptide-inhibitors-that-target-the-ap-1-pathway

EU patent for Phylomer ischemia peptides

  • Europe
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Phylogica has been granted a new European patent (no. 1793841) entitled: ‘Peptide inhibitors of c-Jun dimerization and uses... Read more

patrys-will-start-recruiting-for-the-third-patient-group-for-its-pat-sm6-multiple-myeloma-trial

Patrys gets nod to continue myeloma trial

  • Australia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Patrys received approval to progress its phase I/IIa PAT-SM6 multiple myeloma trial based on safety data from its second group... Read more

astrazeneca-alchemia-sign-usd240-mn-drug-deal

AstraZeneca, Alchemia sign $240 mn drug deal

  • Australia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Alchemia signed a multi-target, drug discovery collaboration with AstraZeneca. The collaboration includes the use of the proprietary... Read more

singapore-health-sciences-authority-hsa-nod-for-aslan-pharma-rheumatoid-arthritis-drug-aslan003

HSA nod for Aslan rheumatoid arthritis drug

  • Singapore
  • |
  • Regulatory
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Aslan Pharmaceuticals received approval by the Singapore Health Sciences Authority (HSA) for its Clinical Trial Certificate Application... Read more

dr-george-rosenkranz-the-winner-of-the-2013-biotechnology-heritage-award-by-chemical-heritage-foundation-chf-and-biotechnology-industry-organization-bio

Steroid pioneer gets Heritage Foundation, BIO award

  • US
  • |
  • Influencers
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Chemical Heritage Foundation (CHF) and Biotechnology Industry Organization (BIO) have selected Mexican steroid scientist, Dr... Read more

Special Features

Survey Box

Chinese Bird Flu H5N7

Have Chinese scientists done the right thing by fusing human and avian flu strains to create new killer viruses?

Send this article by email

X